Holders — by stockHoldings — by fund
Euclidean Capital LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001825034
$439.8M
disclosed book value
11
positions
61.8%
largest position share
Positions, as of 2026-06-30
top 11 of 11 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | VEUVANGUARD INTL EQUITY INDEX F | 3.2M | $271.6M | 61.8% |
| 2 | VTVVANGUARD INDEX FDS | 520,000 | $113.3M | 25.8% |
| 3 | INDAISHARES TR | 369,600 | $18.3M | 4.2% |
| 4 | ORICORIC PHARMACEUTICALS INC | 989,410 | $10.7M | 2.4% |
| 5 | TMSTEAMSHARES INC | 1.1M | $9.0M | 2.1% |
| 6 | FHTXFOGHORN THERAPEUTICS INC | 1.6M | $7.7M | 1.7% |
| 7 | PMVPPMV PHARMACEUTICALS INC | 2.6M | $3.5M | 0.8% |
| 8 | ALECALECTOR INC | 1.3M | $2.6M | 0.6% |
| 9 | SRZNSURROZEN INC | 87,696 | $2.3M | 0.5% |
| 10 | TNYATENAYA THERAPEUTICS INC | 1.0M | $750,708 | 0.2% |
| 11 | SURROZEN INC | 170,833 | $2,819 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.